Croce Carlo M
Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, 410 West 10th Avenue, Columbus, OH 43210, USA.
Nat Rev Genet. 2009 Oct;10(10):704-14. doi: 10.1038/nrg2634.
Over the past several years it has become clear that alterations in the expression of microRNA (miRNA) genes contribute to the pathogenesis of most--if not all--human malignancies. These alterations can be caused by various mechanisms, including deletions, amplifications or mutations involving miRNA loci, epigenetic silencing or the dysregulation of transcription factors that target specific miRNAs. Because malignant cells show dependence on the dysregulated expression of miRNA genes, which in turn control or are controlled by the dysregulation of multiple protein-coding oncogenes or tumour suppressor genes, these small RNAs provide important opportunities for the development of future miRNA-based therapies.
在过去几年中,很明显,微小RNA(miRNA)基因表达的改变促成了大多数(即便不是全部)人类恶性肿瘤的发病机制。这些改变可由多种机制引起,包括涉及miRNA基因座的缺失、扩增或突变、表观遗传沉默或靶向特定miRNA的转录因子失调。由于恶性细胞表现出对miRNA基因失调表达的依赖性,而miRNA基因又反过来控制多个蛋白质编码癌基因或肿瘤抑制基因的失调或受其调控,因此这些小RNA为未来基于miRNA的治疗方法的开发提供了重要机会。